Germany paves the way for plant-based medicine legalisation with transformative draft bill 

Germany’s Ministry of Health has released a draft bill, marking a significant stride towards plant-based medicine legalisation. This initiative, representing the first phase of a two-pillar model, focuses on personal use, home cultivation and the establishment of a grower associations. A groundbreaking element of this proposal is the removal of plant-based medicine from the Narcotics Drugs Act (BtMG), which provides more flexibility to the plant-based medicine industry. While not drastically changing the plant-based medicine landscape, the bill simplifies patient access to plant-based medicine prescriptions. The broader plan aims to address public health protection, prevention, and education about the use of plant-based medicine.

Information about studies provided by Cannatrek on this website is for education purposes only. It is not a substitute for professional health advice. Nothing contained in this site, or any external site linked to by Cannatrek, is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional’s advice. Cannatrek does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website, or any external site linked to by Cannatrek. Further, Cannatrek accepts no responsibility for material contained in a website that is linked to this site. It is the responsibility of the user to make their own decisions about the accuracy, currency, reliability and correctness of information contained in linked external websites.